Evidence map›Paper›PMID 16817954›Full record

ReviewOrphanet journal of rare diseases2006

Hypersensitivity pneumonitis.

Yves Lacasse, Yvon Cormier

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Occupational hypersensitivity pneumonia.Tuberkuloz ve toraks · 2023
    Review
  9. Review
  10. Review
  11. Zoonotic diseases from birds to humans in Vietnam: possible diseases and their associated risk factors.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
  12. Article
  13. Article
  14. Hypersensitivity pneumonitis: an overlooked cause of cough and dyspnea.Journal of community hospital internal medicine perspectives · 2017
    Article
  15. A Case of Chronic Cough in a Winemaker.Respiratory medicine case reports · 2017
    Article
  16. Hypersensitivity pneumonitis: a complex lung disease.Clinical and molecular allergy : CMA · 2017
    Review
  17. Imaging of Hypersensitivity Pneumonitis.Radiologic clinics of North America · 2016
    Review
  18. Review
  19. Chronic hypersensitivity pneumonitis.Journal of asthma and allergy · 2016
    Review
  20. Spotlight on the diagnosis of extrinsic allergic alveolitis (hypersensitivity pneumonitis).Journal of occupational medicine and toxicology (London, England) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yves LacasseCentre de Pneumologie, Université Laval, Hôpital Laval, 2725 Chemin Ste-Foy, Ste-Foy, Quebec, G1V 4G5, Canada. yves.lacasse@med.ulaval.ca
Yvon Cormier
Université Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypersensitivity pneumonitis (HP) is a pulmonary disease with symptoms of dyspnea and cough resulting from the inhalation of an antigen to which the subject has been previously sensitized. The incidence of HP is unknown. A population-based study estimated the annual incidence of interstitial lung diseases as 30:100,000 and HP accounted for less than 2% of these cases. The diagnosis of HP can often be made or rejected with confidence, especially in areas of high or low prevalence respectively, using simple diagnostic criteria. Chest X-rays may be normal in active HP; High Resolution Computed Tomography is sensitive but not specific for the diagnosis of HP. The primary use of pulmonary function tests is to determine the physiologic abnormalities and the associated impairment. Despite the pitfalls of false positive and false negatives, antigen-specific IgG antibodies analysis can be useful as supportive evidence for HP. Bronchoalveolar lavage plays an important role in the investigation of patients suspected of having HP. A normal number of lymphocytes rules out all but residual disease. Surgical lung biopsy should be reserved for rare cases with puzzling clinical presentation or for verification the clinical diagnosis when the clinical course or response to therapy is unusual. Being an immune reaction in the lung, the most obvious treatment of HP is avoidance of contact with the offending antigen. Systemic corticosteroids represent the only reliable pharmacologic treatment of HP but do not alter the long-term outcome. The use of inhaled steroids is anecdotal. Treatment of chronic or residual disease is supportive.

Indexed as

AdultAlveolitis, Extrinsic AllergicDiagnosis, DifferentialFarmer's LungGlobal HealthHumansIncidenceLung DiseasesPrevalence

Identifiers

PMID16817954
PMCPMC1533805
OpenAlexW4246369835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.